Skip to content
Screener

Omega Healthcare Investors OHI Accounts Receivable, Credit Loss Expense (Reversal)

Accounts Receivable, Credit Loss Expense (Reversal) at other companies

LTC Properties logo
LTC PropertiesLTC
$27K-93.0%
Sabra Healthcare logo
Sabra HealthcareSBRA
——
Jones Lang LaSalle logo
Jones Lang LaSalleJLL
——

Other financials

Income statement

See full
Revenue$328.2M+16.2%
Net income$362.8M+166%
EPS (diluted)$1.19+159%

Balance sheet

See full
Cash & equivalents$39.0M-94.7%
Total debt$29.5M-2.7%
Total equity$5.4B+8.1%
Total assets$10.0B-5.0%

Cash flow

See full
Operating cash flow$217.7M-9.0%
CapEx$17.9M+40.3%
Free cash flow$199.8M-11.8%

Valuation

See full
Market cap$14.36B+21.1%
P/E16.7×-8.1×
P/S11.2×+0.6×

Profitability

See full
Operating margin43.5%—
Net margin67%+24.2pp
FCF margin63.6%-6.2pp

Returns & leverage

See full
Return on equity16.5%+5.6pp
Debt / equity0×0.0×

Where this comes from

Reported directly by Omega Healthcare Investors in its filing.

Tagged under the XBRL concept us-gaap:ProvisionForDoubtfulAccounts.

The source filing: Omega Healthcare Investors’s 10-Q, filed July 30, 2026.

Filed
Jul 30, 2026, 11:13 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000888491-26-000024
Line itemThree Months Ended / June 30, 2026Three Months Ended / June 30, 2025Six Months Ended / June 30, 2026Six Months Ended / June 30, 2025
General and administrative41,99723,31867,58454,860
Acquisition, merger and transition related costs4,6602,0105,7743,474
Impairment on real estate properties—14,21539215,450
(Recovery) provision for credit losses(5,019)(4,771)(8,313)321
Total expenses187,793171,949354,930347,263
Other income (expense)
Other (expense) income – net(7,215)13,751(6,139)16,798
Gain on assets sold – net246,51922,886249,54332,961

Item 1. Financial Statements of Omega Healthcare Investors, Inc. (Unaudited):

FAQ

What is Omega Healthcare Investors's accounts receivable, credit loss expense (reversal)?
Omega Healthcare Investors (OHI) reported accounts receivable, credit loss expense (reversal) of -$5.02M in Q2 2026.
How has Omega Healthcare Investors's accounts receivable, credit loss expense (reversal) changed year-over-year?
Omega Healthcare Investors's accounts receivable, credit loss expense (reversal) decreased by 5.2% year-over-year, from -$4.77M to -$5.02M.
What is the long-term trend for Omega Healthcare Investors's accounts receivable, credit loss expense (reversal)?
Over 4 years (2021 to 2025), Omega Healthcare Investors's accounts receivable, credit loss expense (reversal) has grown at a -58.4% compound annual growth rate (CAGR), from $77.73M to $2.34M.

Ask your AI about Omega Healthcare Investors's accounts receivable, credit loss expense (reversal).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude